Exactly! With a worldwide pandemic, one that may eventually impact every
human on the planet, AMRN has a medication that may be key to providing
a remedy to the residual health impact (for many) from having had this
virus. Early on it was determined that the virus resulted in inflammation
of the Endothelium...This is EXACTLY the area that Vascepa has been shown
to reduce the inflammation of and help to heal! WHY CAN'T AMRN GET
TRACTION ON THIS? Simple answer: They can't even gain traction for
having a medication that helps remedy the biggest killer on the planet,
CVD.
So is the problem management? Is it a vast conspiracy of BP to keep
Vascepa from gaining a foothold? Is it the seeming inability of the FDA
to do their job in a way that benefits and protects the health of the
citizens which they are there to serve? Is it the "political agenda"
that only benefits those that "they" choose to benefit? Is it all of
above? (Hint...Who is Steve Nissen and why is he so strangely negative?)
The solution is obvious. For the sake of those who would benefit from
this amazing medication let us hope that the AMRN board of directors
come to the same conclusion that I have a long time ago.
Market Data 
Markets 
AI
